NI
THRX

Nextech Invest’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Nextech Invest’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-611,310
Closed -$1.64M – 16
2023
Q3 		$1.64M Hold
611,310
– – 0.5% 13
2023
Q2 		$5.7M Hold
611,310
– – 1.94% 10
2023
Q1 		$5.43M Hold
611,310
– – 2.27% 9
2022
Q4 		$3.04M Hold
611,310
– – 1.21% 12
2022
Q3 		$3.55M Hold
611,310
– – 1.15% 13
2022
Q2 		$3.38M Hold
611,310
– – 1.14% 13
2022
Q1 		$7.05M Hold
611,310
– – 2.01% 13
2021
Q4 		$7.75M Buy
+611,310
New +$9.23M 2.04% 11

Other funds holding THRX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Nextech Invest's THRX Position: Q4 2023 in Review

Nextech Invest sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q4 2023, closing a stake of 611,310 shares — an estimated $1.64M sold.

Nextech Invest first reported a position in THRX in Q4 2021 and held it in 8 quarters. The position peaked at $7.75M in Q4 2021. 70 funds tracked by Wall St. Rank hold THRX as of Q4 2023.

  • Nextech Invest reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Nextech Invest sold 611,310 Theseus Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $1.64M.
  • Nextech Invest first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Nextech Invest's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $7.75M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Nextech Invest's 13F filing for Q4 2023, filed 14 Feb 2024.